Systemic antigen in the treatment of T-cell-mediated autoimmune diseases
- 1 December 1997
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 18 (12) , 599-604
- https://doi.org/10.1016/s0167-5699(97)01171-7
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Late Complications of Immune Deviation Therapy in a Nonhuman PrimateScience, 1996
- The Roles of Fas/APO-1 (CD95) and TNF in Antigen-Induced Programmed Cell Death in T Cell Receptor Transgenic MiceImmunity, 1996
- A License to KillCell, 1996
- Altered Peptide Ligand–Induced Partial T Cell Activation: Molecular Mechanisms and Role in T Cell BiologyAnnual Review of Immunology, 1996
- Peripheral tolerance in T cell receptor‐transgenic mice: Evidence for T cell anergyEuropean Journal of Immunology, 1996
- Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseasesImmunology Today, 1995
- T Cell Deletion in High Antigen Dose Therapy of Autoimmune EncephalomyelitisScience, 1994
- T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptidesEuropean Journal of Immunology, 1993
- Inhibition of a novel model of murine experimental autoimmune orchitis by intravenous administration with a soluble testicular antigen: Participation of CD8+ regulatory T cellsClinical Immunology and Immunopathology, 1992
- Specific Inhibition of Antibody Formation During Immunological Paralysis and UnresponsivenessNature, 1959